Top Markets
#1 Siren Siren +34.02%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.12%
#3 Ribbita by Virtuals Ribbita by Virtuals +19.89%
#4 Wiki Cat Wiki Cat +18.72%
#5 Bitway Bitway +17.12%
#6 PulseChain PulseChain +16.92%
#7 Cysic Cysic +16.87%
#8 Velvet Velvet +16.81%
#9 KUB Coin KUB Coin +15.48%
#10 Wrapped Bitcoin (PulseChain) Wrapped Bitcoin (PulseChain) +14.91%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Pharmala Biotech Holdings Inc. Pharmala Biotech Holdings Inc.

Pharmala Biotech Holdings Inc.

MDMA
Rank in Stocks #30974
Pharmala Biotech Holdings Inc., operating as PharmAla, concentrates its efforts... Pharmala Biotech Holdings Inc., operating as PharmAla, concentrates its efforts on the research, manufacturing, and bringing to market of active pharmaceutical ingredients (APIs) within the substituted methylenedioxy-phenethylamine (MDXX) class. The company's offerings further extend to various MDXX class compounds, such as 1,3-Benzodioxolyl-Nmethylbutanamine (MBDB) and 3,4-Methylenedioxy-N-ethylamphetamine (MDEA/MDE), in addition to prepared formulations of these MDXX substances. The enterprise maintains its primary corporate offices in Vancouver, Canada.
Share Price
$0.13577832
Market Cap
$14.83M
Change (1 day)
-2.63%
Change (1 year)
44.13%
Country
CA
Trade Pharmala Biotech Holdings Inc. (MDMA)

Category

Healthcare
Earnings for Pharmala Biotech Holdings Inc. (MDMA)
Earnings in 2026 TTM: 0
According to Pharmala Biotech Holdings Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Pharmala Biotech Holdings Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
$1.61B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE